ArticleJournal of neuroendocrinology2026
Comparative analysis of SCGN expression patterns in the anterior pituitary gland of mouse, pig, and human by single-cell transcriptomics.
Article in Journal of neuroendocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Secretagogin (SCGN) is a calcium-binding protein implicated in neuroendocrine secretion. However, its expression profile in the anterior pituitary gland and potential species-specific differences remain poorly characterized. We analyzed scRNA-seq data from the pituitary glands of mice, rats, pigs, and humans, then combined it with validation by immunostaining to systematically elucidate the expression and distribution patterns of SCGN in the anterior pituitary gland. SCGN exhibited distinct species-specific expression patterns. In mice, SCGN transcripts were predominantly enriched in PIT1-lineage lactotropes and SF1-lineage gonadotropes, with immunofluorescence confirming high colocalization with LH, FSH, and PRL. In pigs, SCGN was primarily expressed in TPIT-lineage corticotropes, and immunofluorescence colocalization analysis confirmed the highest colocalization rate with ACTH. In humans, SCGN expression was confirmed in the anterior pituitary gland by immunohistochemistry, while scRNA-seq revealed predominant enrichment of its transcripts in PIT1-lineage lactotropes and somatotropes. Notably, comparative interspecies analysis indicated a high degree of similarity in SCGN enrichment within PIT1-lineage cells (particularly lactotropes) between mice and humans. In contrast, SCGN expression was undetectable in the rat anterior pituitary gland at both transcriptional and protein levels. Together, our findings suggest that SCGN may not be an essential or universal regulator of anterior pituitary hormone secretion. Instead, this study provides an informative negative example that highlights the interspecies divergence of the pituitary secretory machinery among mammals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.